miR-141 suppresses the growth and metastasis of HCC cells by targeting E2F3

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• MicroRNAs (miRNAs) are crucial post-transcriptional regulators of gene expression.
• Aberrant miRNA expression is implicated in various cancers, including hepatocellular carcinoma (HCC).
• The specific role of miR-141 in HCC progression and metastasis remains to be fully elucidated.

Purpose of the Study:

• To investigate the function of miR-141 in hepatocellular carcinoma (HCC).
• To identify the molecular targets of miR-141 in HCC.
• To determine the therapeutic potential of miR-141 in HCC treatment.

Main Methods:

• Quantitative real-time PCR (qRT-PCR) to assess miR-141 expression levels in HCC tissues and cell lines.
• In vitro assays (proliferation, migration, invasion) to evaluate the functional impact of miR-141.
• Western blotting and luciferase reporter assays to confirm E2F3 as a direct target of miR-141.

Main Results:

• miR-141 expression was significantly downregulated in HCC tissues and cell lines compared to normal controls.
• Overexpression of miR-141 inhibited HCC cell proliferation, migration, and invasion.
• E2F transcription factor 3 (E2F3) was validated as a direct downstream target of miR-141.
• Re-expression of E2F3 rescued the tumor-suppressive effects induced by miR-141 restoration.

Conclusions:

• miR-141 acts as a tumor suppressor in hepatocellular carcinoma.
• The miR-141/E2F3 axis plays a critical role in regulating HCC cell metastasis.
• Targeting miR-141 may represent a novel therapeutic strategy for inhibiting HCC progression.